Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

Clinical trial NCT00162006 · COMPLETED

Trial details

NCT number

NCT00162006

Sponsor

Baxalta now part of Shire

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2003-01-13

Primary completion

2003-12-03

Enrollment

28

View on ClinicalTrials.gov